Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Felder

Showing results (181-190 of 186) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 186 results.
Journal of Viral Hepatitis|October 27, 2004
A randomized trial of prolonged high dose of interferon plus ribavirin for hepatitis C patients nonresponders to interferon aloneG Fattovich, I Zagni, M L Ribero, et al.
Alimentary Pharmacology & Therapeutics|February 12, 2016
Years of life that could be saved from prevention of hepatocellular carcinomaA Cucchetti, F Trevisani, L Bucci, et al.
Alimentary Pharmacology & Therapeutics|December 15, 2015
Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatment and outcomeL Bucci, F Garuti, V Camelli, et al.
Current Pharmaceutical Design|April 12, 2002
Tamoxifen in the treatment of hepatocellular carcinoma: 5-year results of the CLIP-1 multicentre randomised controlled trialF Perrone, C Gallo, B Daniele, et al.
Alimentary Pharmacology & Therapeutics|October 30, 2016
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferonS Petta, G Cabibbo, M Barbara, et al.
Nature|May 6, 2005
The genome of the social amoeba Dictyostelium discoideumL Eichinger, J A Pachebat, G Glöckner, et al.
Pageof 19

Showing results (181-190 of 186) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 186 results.
Journal of Viral Hepatitis|October 27, 2004
A randomized trial of prolonged high dose of interferon plus ribavirin for hepatitis C patients nonresponders to interferon aloneG Fattovich, I Zagni, M L Ribero, et al.
Alimentary Pharmacology & Therapeutics|February 12, 2016
Years of life that could be saved from prevention of hepatocellular carcinomaA Cucchetti, F Trevisani, L Bucci, et al.
Alimentary Pharmacology & Therapeutics|December 15, 2015
Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatment and outcomeL Bucci, F Garuti, V Camelli, et al.
Current Pharmaceutical Design|April 12, 2002
Tamoxifen in the treatment of hepatocellular carcinoma: 5-year results of the CLIP-1 multicentre randomised controlled trialF Perrone, C Gallo, B Daniele, et al.
Alimentary Pharmacology & Therapeutics|October 30, 2016
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferonS Petta, G Cabibbo, M Barbara, et al.
Nature|May 6, 2005
The genome of the social amoeba Dictyostelium discoideumL Eichinger, J A Pachebat, G Glöckner, et al.
Pageof 19